Dear user of the Accu-Chek Spirit Combo insulin pump,
Do not use your insulin pump for the delivery of medication other
than U100 rapid-acting insulin. Before using a different insulin
with the Accu-Chek Spirit Combo insulin pump, check the insulin
label and accompanying documents to make sure it can be used
with this device.
Also consult the instructions for use coming with your insulin,
infusion set, and additional devices used for your insulin therapy.
Your Accu-Chek Spirit Combo insulin pump is a valuable medical
device. We strongly encourage you to add your insulin pump to
your home contents insurance policy to protect you in case of
accidental damage or loss. Ask your insurance agent for details.
This User’s Manual is provided for you, as a person with
diabetes, and for healthcare professionals. It contains all the
necessary information for the safe and efficient use of your
Accu-Chek Spirit Combo insulin pump. Regardless of your level
of experience with pump therapy, please read this User’s Manual
carefully before beginning insulin pump therapy. Always refer to
this User’s Manual first, when you have questions about or have
problems using your insulin pump. If you cannot find the solution
to your problem in this document, we recommend that you
contact your Accu-Chek Customer Care. You will find the address
and phone number on the inside back cover of this manual.
Intended Use of the Accu-Chek Spirit Combo insulin pump
The Accu-Chek Spirit Combo insulin pump is intended for the
subcutaneous continuous delivery of insulin at set and variable
rates, for the management of diabetes mellitus in persons
requiring insulin as prescribed by a physician.
The Accu-Chek Spirit Combo insulin pump is intended for the use
of U 100 rapid-acting insulin. Humalog
®
(insulin lispro, rDNA
origin)*, Apidra
®
(insulin glulisine, rDNA origin)** and NovoLog
®
(insulin aspart)*** have been tested and found to be safe for use
in the Accu-Chek Spirit Combo insulin pump.
* Humalog
®
is a registered trademark of Eli Lilly and Company.
** Apidra
®
is a registered trademark of the sanofi-aventis group.
*** NovoLog
®
is a registered trademark of Novo Nordisk A/S.
man_05504929001_H_en-us.indb 4 01.06.2016 08:14:31
